Skip to main content
Lee's Pharmaceutical Holdings Limited logo

Lee's Pharmaceutical Holdings Limited — Investor Relations & Filings

Ticker · 950 LEI · 21380057SDS1LER3KZ63 HKEX Manufacturing
Open in API
Filings indexed 799 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 950

About Lee's Pharmaceutical Holdings Limited

http://www.leespharm.com

Lee's Pharmaceutical Holdings Limited is a research-driven and market-oriented biopharmaceutical company with over 30 years of operation. The company is fully integrated, possessing capabilities in drug development, clinical trials, manufacturing, marketing, and sales of internationally approved pharmaceutical products. Its core mission is centered on R&D of innovative products to address unmet medical needs and improve patients’ quality of life, primarily serving the pharmaceutical industry in China. The product portfolio, stemming from internal efforts and collaborations, addresses various therapeutic areas, including rare diseases (such as pulmonary hypertension) and dermatology. Manufacturing operations are supported by self-owned sites in Hefei and Nansha.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-04 English
Notification Letter to Non-registered Shareholders and Reply Form
Report Publication Announcement Classification · 1% confidence The document is a ‘Notification Letter’ informing non-registered shareholders that the Company’s Annual Report and Circular have been published online, with instructions on how to obtain printed copies. It does not contain the actual financial content or Circular itself, but merely announces the publication and availability of those reports. Under the “Menu vs Meal” rule, this is a Report Publication Announcement.
2026-04-24 English
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement Classification · 1% confidence The document is a shareholder notification dated 24 April 2026 informing registered shareholders that the Company’s annual report, circular and proxy form (collectively the “Current Corporate Communication”) have been published online and providing instructions for electronic dissemination and how to request printed copies. It does not contain the actual annual report or detailed financial data, but merely announces the publication and access arrangements. Therefore, it is a report publication announcement.
2026-04-24 English
Proxy Form
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder proxy form to solicit votes at the Annual General Meeting, including resolutions and instructions on appointing a proxy. This falls under Proxy Solicitation & Information Statement materials (PSI), rather than an AGM presentation, annual report, or simple announcement.
2026-04-23 English
Notice of Annual General Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice convening the Annual General Meeting (AGM) of Lee’s Pharmaceutical Holdings Limited, listing resolutions to be voted on and providing proxy and meeting details. It is not the meeting materials/presentation itself, nor the published report, but rather the proxy solicitation/information statement for shareholders to vote. Therefore, it best fits the Proxy Solicitation & Information Statement category.
2026-04-23 English
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors and Notice of Annual General Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular issued by Lee’s Pharmaceutical Holdings Limited, containing the notice of the Annual General Meeting, explanatory statements on share repurchase and issue mandates, biographical details of directors for re-election, and proxy form instructions. It is designed to solicit proxies and inform shareholders ahead of a vote. This matches the definition of a "Proxy Solicitation & Information Statement" (PSI).
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.